Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
FDA charges data integrity issues in Wockhardt factories
Description
Drugmaker Wockhardt's pending regulatory issues with US Food and Drug Adminstration is getting murkier as the latest observations made by the US drug regulator suggests the Indian drugmaker has manipulated data related to tests and trials of drugs. Mint's C H Unnikrishnan has more.
More from User
06:52
Jet Airways crisis: Who is to blame, lending banks or promoter Naresh Goyal?
Mint
01:38
What to expect from Reliance Q4 earnings?
Mint
29:58
Zia Mody on adversarial deal making, fear of missing out in private equity
Mint
19:20
Apex Court squashes RBI's Feb 12 Circular on Stressed Assets Resolution : A Decode
Mint
12:50
Marico Founder Harsh Mariwala on how Indian start-ups can scale up & thrive
Mint
23:10
'Hostile' takeovers: L&T-Mindtree saga signals new era in Indian M&A deals?
Mint
Related Videos
01:32
A peek inside Baba Ramdev’s Patanjali factories
Mint
04:17
Private jet operators challenge Mumbai airport parking charges
Mint
01:15
Reporter's Notebook| Closing a bank account attracts charges
Mint
04:17
Private jet operators challenge Mumbai airport parking charges
Mint
01:13
Cash transactions at HDFC, ICICI, Axis banks attract charges
Mint
01:48
CBI charges Naveen Jindal, 14 others in coal block allocation case
Mint